The potential role of IL-37 in atherosclerosis

Author： Wu Bang-Wei   Zeng Qiu-Tang   Meng Kai   Ji Qing-Wei  

Publisher： Govi-Verlag

ISSN： 0031-7144

Source： Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.68, Iss.11, 2013-11, pp. : 857-860

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

IL-35: a potential target for the treatment of atherosclerosis

By Huang Ying   Lin Ying-Zhong   Shi Ying   Ji Qing-Wei  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 10, 2013-10 ,pp. : 793-795

Govi-Verlag

Access to resources Recommend Favorite

The Role of T and B Cells in Atherosclerosis: Potential Clinical Implications

By  

Current Pharmaceutical Design, Vol. 17, Iss. 37, 2011-12 ,pp. : 4159-4171

Bentham Science Publishers

Access to resources Recommend Favorite

The 9p21 Locus and its Potential Role in Atherosclerosis Susceptibility; Molecular Mechanisms and Clinical Implications

By  

Current Pharmaceutical Design, Vol. 22, Iss. 37, 2016-10 ,pp. : 5730-5737

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Lysophosphatidylcholine (LPC) in Atherosclerosis

By  

Current Medicinal Chemistry, Vol. 14, Iss. 30, 2007-12 ,pp. : 3209-3220

Bentham Science Publishers

Access to resources Recommend Favorite

The role of interleukin 35 in atherosclerosis

By  

Current Pharmaceutical Design, Vol. 21, Iss. 35, 2015-10 ,pp. : 5151-5159

Bentham Science Publishers

Access to resources Recommend Favorite